network member

Washington

About Network Member

Currently Enrolling

TBCRC046

A Phase II Trial of Avelumab or Hydroxychloroquine with or without Palbociclib to Eliminate Dormant Breast Cancer (“PALAVY”)
Cancer areas:Breast
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Research Center
Georgetown Lombardi Comprehensive Cancer Center
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Penn Medicine Abramson Cancer Center
The University of Chicago Medicine Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center